Ovarian function with a novel combined contraceptive vaginal ring

By Mulders Titia M.T.  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2594-2599

Oxford University Press

Access to resources Recommend Favorite

Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 g ethinylestradiol and 150 g levonorgestrel: a randomized trial

By Oddsson K.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 557-562

Oxford University Press

Access to resources Recommend Favorite

A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol

By Tang OS  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 722-725

Oxford University Press

Access to resources Recommend Favorite

A prospective trial comparing oocyte donor ovarian response and recipient pregnancy rates between suppression with gonadotrophin-releasing hormone agonist (GnRHa) alone and dual suppression with a contraceptive vaginal ring and GnRH

By Martínez F.   Boada M.   Coroleu B.   Clua E.   Parera N.   Rodríguez I.   Barri P.N.  

Human Reproduction, Vol. 21, Iss. 8, 2006-08 ,pp. : 2121-2125

Oxford University Press

Access to resources Recommend Favorite

Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 µg ethinyl estradiol and 3 mg drospirenone

By Milsom I.   Lete I.   Bjertnaes A.   Rokstad K.   Lindh I.   Gruber C.J.   Birkhäuser M.H.   Aubeny E.   Knudsen T.   Bastianelli C.  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2304-2311

Oxford University Press

Access to resources Recommend Favorite